Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3890-3899
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3890
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3890
UC groups | VIP score | Fold change (remission/relapse) | P value3 | ||
Remission | Relapse | ||||
Trans-aconitate (urine) | 0.5 (0.5-1.6) | 3.6 (1.9-5.5) | 1.9 | 0.2 | 0.02 |
3-hydroxybutyrate (serum) | 21.0 (15.0-33.9) | 127.8 (37.5-232.0) | 1.4 | 0.2 | < 0.01 |
Cystine (urine) | 5.3 (4.0-8.6) | 3.3 (1.4-5.9) | 1.4 | 2.7 | 0.07 |
Acetamide (urine) | 4.9 (2.7-7.1) | 2.6 (0.8-3.8) | 1.3 | 2.4 | 0.05 |
Acetoacetate (serum) | 7.8 (5.8-13.0) | 25.6 (10.5-60.2) | 1.2 | 0.3 | 0.02 |
Acetone (serum) | 5.3 (4.2-8.7) | 11.9 (6.0-24.7) | 1.1 | 0.4 | 0.06 |
- Citation: Keshteli AH, van den Brand FF, Madsen KL, Mandal R, Valcheva R, Kroeker KI, Han B, Bell RC, Cole J, Hoevers T, Wishart DS, Fedorak RN, Dieleman LA. Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study. World J Gastroenterol 2017; 23(21): 3890-3899
- URL: https://www.wjgnet.com/1007-9327/full/v23/i21/3890.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i21.3890